ACOR - Nasdaq. Acorda Therapeutics has formed a Darvas box entry at a new high following a large expansion in volume. Rising OBV shows us the buyers are in control of this stock. A breakout of the top of the box ($33.00) would constitute a valid entry. A tight Darvas stoploss should be placed just below the $29.00 and raised up after a valid breakout occurs.
Posts
0 comments:
Post a Comment